DA, A., IT, P., BM, B., SH, T., & RM, L. (2014). High hematocrit resulting from administration of erythropoiesis-stimulating agents is not fully predictive of mortality or toxicities in preclinical species. Toxicologic pathology, 42(3), 510. https://doi.org/10.1177/0192623313486317
Chicago Style (17th ed.) CitationDA, Andrews, Pyrah IT, Boren BM, Tannehill-Gregg SH, and Lightfoot-Dunn RM. "High Hematocrit Resulting from Administration of Erythropoiesis-stimulating Agents Is Not Fully Predictive of Mortality or Toxicities in Preclinical Species." Toxicologic Pathology 42, no. 3 (2014): 510. https://doi.org/10.1177/0192623313486317.
MLA (9th ed.) CitationDA, Andrews, et al. "High Hematocrit Resulting from Administration of Erythropoiesis-stimulating Agents Is Not Fully Predictive of Mortality or Toxicities in Preclinical Species." Toxicologic Pathology, vol. 42, no. 3, 2014, p. 510, https://doi.org/10.1177/0192623313486317.